Mohammad Hirmand

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Stephen Rodin, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mohammad Hirmand:

Company Role Class Num Shares Value Price $ Report Date Ownership
Whitehawk Therapeutics, Inc. Director Stock Option (right to buy) 40,006 12 Jun 2025 Direct
Turning Point Therapeutics, Inc. EVP and Chief Medical Officer Common Stock 0 $76.00 17 Aug 2022 Direct
Turning Point Therapeutics, Inc. EVP and Chief Medical Officer Stock Option (right to buy) 0 17 Aug 2022 Direct

Insider Reports Filed by Mohammad Hirmand

Symbol Company Period Transactions Value $ Form Type Role Filing Time
WHWK Whitehawk Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 16:58
WHWK Aadi Bioscience, Inc. 12 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:10
WHWK Aadi Bioscience, Inc. 27 Mar 2023 1 $0 4 Director 29 Mar 2023, 16:20
WHWK Aadi Bioscience, Inc. 27 Mar 2023 0 $0 3 Director 29 Mar 2023, 16:18
/report/000120919122046264-hirmand-mohammad-2022-08-17 Turning Point Therapeutics, Inc. 17 Aug 2022 4 -$3,137,584 4 EVP and Chief Medical Officer 17 Aug 2022, 16:26
/report/000120919122008980-hirmand-mohammad-2022-02-09 Turning Point Therapeutics, Inc. 09 Feb 2022 4 -$24,285 4 EVP & Chief Medical Officer 11 Feb 2022, 17:08